PRELUDE THERAPEUTICS INC (PRLD) Shareholders’ equity 2024–2025
PRELUDE THERAPEUTICS INC (PRLD) shareholders’ equity at each fiscal year-end, per SEC filings.
$68.6MFY2025 · since FY2024: $131.5M → $68.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $68.6M | -47.8% |
| FY2024 | $131.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice